shyamaladevi Babu

Dr. shyamaladevi Babu

saveeetha dental college
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SBshyamaladevi Babu
shyamaladevi Babu
SJSelvaraj Jayaraman
Selvaraj Jayaraman
Phytosterols are bioactive compounds that are naturally present in plant cell membranes with chemical structure similar to the mammalian cell- derived cholesterol. They are highly present in lipid-rich plant foods such as nuts, seed, legumes and olive oil. Among various phytosterols, β-sitosterol (SIT) is the major compound, found plentiful in plants. It has been evidenced in many in-vitro and in-vivo studies that SIT possesses various biological actions such as anxiolytic & sedative effects, analgesic, immunomodulatory, antimicrobial, anticancer, anti - inflammatory, lipid lowering effect, hepatoprotective, protective effect against NAFLD and respiratory diseases, wound healing effect, antioxidant and anti-diabetic activities. In this review, in order to compile the sources, characterization, biosynthesis, pharmacokinetics, antioxidant and anti-diabetic activities of SIT, classical and online-literature were studied which includes the electronic search (Sci Finder, Pubmed, Google Scholar, Scopus, and Web of Science etc) and books on photochemistry. The experimental studies on SIT gives a clear evidence that the potential phytosterol can be used as supplements to fight against life threatening diseases. High potential of this compound, classifies it as the notable drug of the future. Therefore, immense researches regarding its action at molecular level on life threatening diseases in humans are highly endorsed.

15 January 2019 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
RPR. Ponnulakshmi
R. Ponnulakshmi
SBshyamaladevi Babu
shyamaladevi Babu
PVP. Vijayalakshmi
P. Vijayalakshmi
SJSelvaraj Jayaraman
Selvaraj Jayaraman
Adipose tissue is the primary site of storage for excess energy as triglyceride and it helps in synthesizing a number of biologically active compounds that regulate metabolic homeostasis. Consumption of high dietary fat increases stored fat mass and is considered as a main risk factor for metabolic diseases. Beta-sitosterol (β-sitosterol) is a plant sterol. It has the similar chemical structure like cholesterol. Clinical and experimental studies have shown that β-sitosterol has anti-diabetic, hypolipidemic, anti-cancer, anti-arthritic and hepatoprotective role. However, effect of β-sitosterol on insulin signaling molecules and glucose oxidation has not been explored. Hence in the present study we aimed to discover the protective role of β-sitosterol on the expression of insulin signaling molecules in the adipose tissue of high-fat diet and sucrose-induced type-2 diabetic experimental rats. Effect dose of β-sitosterol (20mg/kg b.wt, orally for 30 days) was given to high fat diet and sucrose-induced type-2 diabetic rats to study its anti-diabetic activity. Results of the study showed that the treatment with β-sitosterol to diabetes-induced rats normalized the altered levels of blood glucose, serum insulin and testosterone, lipid profile, oxidative stress markers, antioxidant enzymes, insulin receptor (IR) and glucose transporter 4 (GLUT4) proteins. Our present findings indicate that β-sitosterol improves glycemic control through activation of IR and GLUT4 in the adipose tissue of high fat and sucrose-induced type-2 diabetic rats. Insilico analysis also coincides with invivo results. Hence it is very clear that β-sitosterol can act as potent antidiabetic agent.

6 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SJSelvaraj Jayaraman
Selvaraj Jayaraman
NDNALINI DEVARAJAN
NALINI DEVARAJAN
PRPonnulakshmi Rajagopal
Ponnulakshmi Rajagopal
SBshyamaladevi Babu
shyamaladevi Babu
GKG Senthil Kumar
G Senthil Kumar
KCKirubhanand Chandrasekar
Kirubhanand Chandrasekar
β-sitosterol (SIT), the most abundant bioactive component of vegetable oil and other plants, is a highly potent antidiabetic drug. Our previous studies show that SIT controls hyperglycemia and insulin resistance by activating insulin receptor and glucose transporter 4 (GLUT-4) in the adipocytes of obesity induced type 2 diabetic rats. The current research was undertaken to investigate if SIT could also exert its antidiabetic effects by circumventing adipocyte induced inflammation, a key driving factor for insulin resistance in obese individuals. Effective dose of SIT (20 mg/kg b.wt) was administered orally for 30 days to high fat diet and sucrose induced type-2 diabetic rats. Metformin, the conventionally used antidiabetic drug was used as a positive control. Interestingly, SIT treatment restores the elevated serum levels of proinflammatory cytokines including leptin, resistin, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) to normalcy and increases anti-inflammatory adipocytokines including adiponectin in type 2 diabetic rats. Furthermore, SIT decreases sterol regulatory element binding protein-1c (SREBP-1c) and enhances Peroxisome Proliferator–activated receptor-γ (PPAR-γ) gene expression in adipocytes of diabetic rats. The gene and protein expression of c-Jun-N-terminal kinase-1 (JNK1), inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) and nuclear factor kappa B (NF-κB) were also significantly attenuated in SIT treated groups. More importantly, SIT acts very effectively as metformin to circumvent inflammation and insulin resistance in diabetic rats. Our results clearly show that SIT inhibits obesity induced insulin resistance by ameliorating the inflammatory events in the adipose tissue through the downregulation of IKKβ/NF-κB and c-Jun-N-terminal kinase (JNK) signaling pathway.

1 April 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SBshyamaladevi Babu
shyamaladevi Babu
MKMadhan Krishnan
Madhan Krishnan
PRPonnulakshmi Rajagopal
Ponnulakshmi Rajagopal
VPVijayalakshmi Periyasamy
Vijayalakshmi Periyasamy
VVVishnupriya Veeraraghavan
Vishnupriya Veeraraghavan
SJSelvaraj Jayaraman
Selvaraj Jayaraman

15 May 2023 in Life Sciences
Verified
Journal Article
Closed access
SBshyamaladevi Babu
shyamaladevi Babu
MKMadhan Krishnan
Madhan Krishnan
APArjunkumar Panneerselvam
Arjunkumar Panneerselvam
MCMayilvanan Chinnaiyan
Mayilvanan Chinnaiyan

26 February 2018 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SPSrinivasan Perumal
Srinivasan Perumal
KLKulanthaivel Langeshwaran
Kulanthaivel Langeshwaran
SJSelvaraj Jayaraman
Selvaraj Jayaraman
RPRajagopal Ponnulakshmi
Rajagopal Ponnulakshmi
SBshyamaladevi Babu
shyamaladevi Babu
MBM. P. Balasubramanian
M. P. Balasubramanian